SCHEMBL7003449

SCHEMBL7003449

N=C(N)NCc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.60

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 14/20 0.60
KDR P35968 5/20 0.60
CDK1 P06493 1/20 0.56
CDK2 P24941 1/20 0.56
SGK1 O00141 1/20 0.48
CHEK2 O96017 1/20 0.48
PRKCG P05129 1/20 0.48
AKT1 P31749 1/20 0.48
AKT2 P31751 1/20 0.48
MARK2 Q7KZI7 1/20 0.48
AKT3 Q9Y243 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998707 0.82 KDR (0.57) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7089915 0.80 CHEK1 (0.68) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7698769 0.79 KDR (0.58) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7092553 0.79 CDK1 (0.71) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7091508 0.77 KDR (0.56) CHEK1KDRCDK1CDK2SGK1
SCHEMBL4818484 0.77 KDR (0.62) CHEK1KDR
SCHEMBL7000053 0.77 CHEK1 (0.97) CHEK1KDRCDK1CDK2
SCHEMBL7002715 0.77 KDR (0.78) CHEK1KDRCDK1CDK2
SCHEMBL7701855 0.77 NAMPT (0.64) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6997102 0.76 KDR (0.68) CHEK1KDRCDK1CDK2SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268437-A1 INHIBITORS OF PROTEIN KINASES Knoll GmbH (DE) 2003-01-02 EP disclosed
WO-2002030908-A1 INHIBITORS OF PROTEIN KINASES KNOLL GMBH (DE) 2002-04-18 WO disclosed
US-6297238-B1 3-ARYL PYRAZOLES WITH 4,5(3,4)-BICYCLIC RING FUSION WHICH ARE INHIBITORS OF PROTEIN KINASES PARTICULARLY TYROSINE KINASES AND SERINE/THREONINE KINASES BASF AKTIENGESELLSCHAFT (DE) 2001-10-02 US disclosed